Notice2023-17186
National Cancer Institute; Cancellation of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 10, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 153 (Thursday, August 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 153 (Thursday, August 10, 2023)]
[Notices]
[Page 54331]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-17186]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Cancellation of Meeting
Notice is hereby given of the cancellation of the National Cancer
Institute Special Emphasis Panel, National Cancer Institute Special
Emphasis Panel; SEP-9: NCI Clinical and Translational Cancer Research,
October 26, 2023, 12:00 p.m. to October 26, 2023, 4:00 p.m., National
Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W104,
Rockville, Maryland 20850 which was published in the Federal Register
on July 28, 2023, FR Doc 2023-15995, 88 FR 48898.
This meeting is cancelled and will be rescheduled.
Dated: August 7, 2023.
Melanie Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-17186 Filed 8-9-23; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on August 10, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.